Open AccessFibroblast growth factor 21 is related to cisplatin resistance in ovarian cancer
Author(s) -
Qi Zhong,
Lifei wang,
Meng Cheng,
Huiling Yang
Publication year - 2022
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000002095
Subject(s) - fgf21 , ovarian cancer , cancer research , mapk/erk pathway , cisplatin , cancer , fibroblast growth factor receptor 1 , downregulation and upregulation , medicine , biology , signal transduction , fibroblast growth factor , endocrinology , bioinformatics , microbiology and biotechnology , chemotherapy , gene , genetics , receptor